Themis Medicare Limited Cash Flow Conversion Efficiency
Themis Medicare Limited cash flow conversion efficiency. Based on the latest financial reports, Themis Medicare Limited (THEMISMED) has a cash flow conversion efficiency ratio of -0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-14.84 Million ≈ $-160.49K USD) by net assets (Rs3.80 Billion ≈ $41.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Themis Medicare Limited (2006–2026)
Cash flow conversion efficiency of Themis Medicare Limited from 2006 to 2026. This chart illustrates how Themis Medicare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Themis Medicare Limited share price for real-time trading data and today's change.
Themis Medicare Limited Cash Flow Conversion Ratio Explained
Themis Medicare Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Themis Medicare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Themis Medicare Limited ranked by their cash flow conversion efficiency. Also see THEMISMED market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SD Standard Drilling PLC
OL:SDSD
|
0.153x |
|
Bank Capital Indonesia Tbk
JK:BACA
|
0.445x |
|
Goknur Gida Maddeleri Enerji Imalati Ithalat Ihracat Ticaret ve Sanayi A.S.
IS:GOKNR
|
0.004x |
|
First Steamship Co Ltd
TW:2601
|
0.018x |
|
Kencana Agri Limited
F:KEBA
|
0.269x |
|
Team Precision Public Company Limited
BK:TEAM
|
-0.034x |
|
Voss Veksel og Landmandsbank ASA
OL:VVL
|
0.227x |
|
Leaders Technology Investment Co. Ltd
KQ:019570
|
-0.238x |
Annual Cash Flow Conversion Efficiency for Themis Medicare Limited (2006–2026)
The table below shows the annual cash flow conversion efficiency of Themis Medicare Limited from 2006 to 2026. Review Themis Medicare Limited (THEMISMED) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs3.99 Billion ≈ $43.11 Million |
Rs-118.60 Million ≈ $-1.28 Million |
-0.030x | -134.51% |
| 2025-03-31 | Rs4.03 Billion ≈ $43.54 Million |
Rs347.10 Million ≈ $3.75 Million |
0.086x | +47.37% |
| 2024-03-31 | Rs3.78 Billion ≈ $40.84 Million |
Rs220.94 Million ≈ $2.39 Million |
0.059x | +23.40% |
| 2023-03-31 | Rs3.39 Billion ≈ $36.71 Million |
Rs160.93 Million ≈ $1.74 Million |
0.047x | -60.37% |
| 2022-03-31 | Rs2.87 Billion ≈ $31.09 Million |
Rs343.94 Million ≈ $3.72 Million |
0.120x | -54.12% |
| 2021-03-31 | Rs2.19 Billion ≈ $23.63 Million |
Rs569.75 Million ≈ $6.16 Million |
0.261x | +14440.88% |
| 2020-03-31 | Rs1.83 Billion ≈ $19.79 Million |
Rs3.28 Million ≈ $35.49K |
0.002x | -97.41% |
| 2019-03-31 | Rs1.58 Billion ≈ $17.09 Million |
Rs109.23 Million ≈ $1.18 Million |
0.069x | +48.70% |
| 2018-03-31 | Rs1.69 Billion ≈ $18.26 Million |
Rs78.47 Million ≈ $848.62K |
0.046x | +152.43% |
| 2017-03-31 | Rs1.20 Billion ≈ $13.03 Million |
Rs-106.78 Million ≈ $-1.15 Million |
-0.089x | -128.86% |
| 2016-03-31 | Rs788.89 Million ≈ $8.53 Million |
Rs242.32 Million ≈ $2.62 Million |
0.307x | +0.33% |
| 2015-03-31 | Rs589.08 Million ≈ $6.37 Million |
Rs180.34 Million ≈ $1.95 Million |
0.306x | +188.73% |
| 2014-03-31 | Rs561.85 Million ≈ $6.08 Million |
Rs59.57 Million ≈ $644.27K |
0.106x | +25.17% |
| 2013-03-31 | Rs537.17 Million ≈ $5.81 Million |
Rs45.51 Million ≈ $492.12K |
0.085x | +132.21% |
| 2012-03-31 | Rs580.79 Million ≈ $6.28 Million |
Rs-152.73 Million ≈ $-1.65 Million |
-0.263x | -639.73% |
| 2011-03-31 | Rs910.26 Million ≈ $9.84 Million |
Rs44.35 Million ≈ $479.64K |
0.049x | +16.28% |
| 2010-03-31 | Rs833.43 Million ≈ $9.01 Million |
Rs34.92 Million ≈ $377.67K |
0.042x | +145.22% |
| 2009-03-31 | Rs918.65 Million ≈ $9.93 Million |
Rs-85.13 Million ≈ $-920.63K |
-0.093x | -9.87% |
| 2008-03-31 | Rs845.93 Million ≈ $9.15 Million |
Rs-71.35 Million ≈ $-771.58K |
-0.084x | -184.24% |
| 2007-03-31 | Rs691.60 Million ≈ $7.48 Million |
Rs69.24 Million ≈ $748.82K |
0.100x | +155.05% |
| 2006-03-31 | Rs605.21 Million ≈ $6.55 Million |
Rs23.76 Million ≈ $256.92K |
0.039x | -- |
About Themis Medicare Limited
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It provides active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic, anti-diabetic, a… Read more